[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-PRQR":3,"homepage-market-summary":29,"stock-news-PRQR":170},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":14},"PRQR","2026-10-07",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":9,"founded":9,"is_fund":13,"issuer":9,"category":9},"ProQR Therapeutics N.V. Ordinary Shares","Nasdaq",null,"Common Stock","ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.","187",false,{"close":15,"open":15,"high":16,"low":17,"prev_close":18,"change":19,"percent_change":20,"volume":21,"transactions":22,"vwap":23,"high_52w":24,"low_52w":25,"avg_volume_52w":26,"range_52w_percent":27,"record_count":28},1.63,1.64,1.595,1.65,-0.02,-1.21,405998.111738,1979,1.6217,3.1,1.33,690869.9383354064,16.9,3031,{"status":30,"indices":31,"watchlist":74,"sectors":96,"benchmarks":150},"success",[32,39,46,53,59,66],{"symbol":33,"name":34,"price":35,"change":36,"pct_change":37,"is_up":13,"sparkline":38,"date":5},"SPX","S&P 500",7801.77,-17.16,-0.22,"0.0,13.9 2.3,10.5 4.6,12.4 6.9,14.2 9.3,16.0 11.6,11.5 13.9,10.8 16.2,4.8 18.5,4.8 20.8,7.9 23.2,8.0 25.5,6.0 27.8,9.1 30.1,9.8 32.4,10.8 34.7,10.0 37.1,7.0 39.4,4.4 41.7,2.0 44.0,2.9",{"symbol":40,"name":41,"price":42,"change":43,"pct_change":44,"is_up":13,"sparkline":45,"date":5},"NDX","NASDAQ 100",31160.08,-64.4,-0.21,"0.0,15.0 2.3,13.4 4.6,14.8 6.9,16.0 9.3,16.0 11.6,12.9 13.9,11.7 16.2,6.5 18.5,5.0 20.8,6.6 23.2,6.6 25.5,5.8 27.8,7.8 30.1,7.4 32.4,7.0 34.7,6.4 37.1,4.6 39.4,2.9 41.7,2.0 44.0,2.4",{"symbol":47,"name":48,"price":49,"change":50,"pct_change":51,"is_up":13,"sparkline":52,"date":5},"DJI","DOW JONES",51180,-341,-0.66,"0.0,6.3 2.3,2.0 4.6,3.3 6.9,6.0 9.3,11.3 11.6,8.7 13.9,9.5 16.2,6.4 18.5,8.0 20.8,10.9 23.2,12.3 25.5,8.2 27.8,11.2 30.1,12.3 32.4,16.0 34.7,15.8 37.1,13.7 39.4,13.0 41.7,10.8 44.0,13.7",{"symbol":54,"name":55,"price":56,"change":57,"pct_change":37,"is_up":13,"sparkline":58,"date":5},"COMP","NASDAQ Composite",27538.69,-61.2,"0.0,15.1 2.3,12.9 4.6,14.2 6.9,16.0 9.3,16.0 11.6,12.2 13.9,11.3 16.2,6.1 18.5,5.1 20.8,7.7 23.2,7.7 25.5,6.6 27.8,8.7 30.1,8.9 32.4,8.4 34.7,8.3 37.1,5.5 39.4,3.1 41.7,2.0 44.0,2.5",{"symbol":60,"name":61,"price":62,"change":63,"pct_change":64,"is_up":13,"sparkline":65,"date":5},"RUT","RUSSELL 2000",2777,-36.4,-1.29,"0.0,3.5 2.3,2.0 4.6,4.2 6.9,6.7 9.3,8.2 11.6,6.3 13.9,8.0 16.2,6.1 18.5,4.1 20.8,10.7 23.2,11.0 25.5,10.7 27.8,13.1 30.1,14.4 32.4,15.8 34.7,14.3 37.1,11.2 39.4,8.9 41.7,11.4 44.0,16.0",{"symbol":67,"name":68,"price":69,"change":70,"pct_change":71,"is_up":72,"sparkline":73,"date":5},"VIX","CBOE VIX",15.08,0.07,0.47,true,"0.0,2.0 2.3,9.7 4.6,4.9 6.9,4.5 9.3,2.5 11.6,11.3 13.9,13.7 16.2,13.5 18.5,16.0 20.8,12.3 23.2,10.4 25.5,13.5 27.8,8.8 30.1,8.9 32.4,7.8 34.7,7.6 37.1,11.8 39.4,10.9 41.7,12.9 44.0,12.6",[75,82,89],{"symbol":76,"name":77,"price":78,"change":79,"pct_change":80,"is_up":13,"sparkline":81,"date":5},"NVDA","NVIDIA Corp",237.36,-1.88,-0.79,"0.0,16.0 7.3,14.6 14.7,11.8 22.0,8.2 29.3,2.4 36.7,2.0 44.0,4.2",{"symbol":83,"name":84,"price":85,"change":86,"pct_change":87,"is_up":72,"sparkline":88,"date":5},"AAPL","Apple Inc",336.67,3.04,0.91,"0.0,16.0 7.3,9.0 14.7,14.2 22.0,7.7 29.3,9.3 36.7,7.9 44.0,2.0",{"symbol":90,"name":91,"price":92,"change":93,"pct_change":94,"is_up":13,"sparkline":95,"date":5},"TSLA","Tesla Inc",377.75,-2.93,-0.77,"0.0,16.0 7.3,15.0 14.7,15.4 22.0,7.1 29.3,3.0 36.7,2.0 44.0,3.5",[97,102,107,112,117,122,127,132,137,141,145],{"name":98,"etf":99,"change":100,"price":101,"is_up":13},"Technology","XLK",-0.3,201.39,{"name":103,"etf":104,"change":105,"price":106,"is_up":13},"Financials","XLF",-0.48,53.75,{"name":108,"etf":109,"change":110,"price":111,"is_up":72},"Healthcare","XLV",1.03,168.81,{"name":113,"etf":114,"change":115,"price":116,"is_up":13},"Consumer Cycl","XLY",-0.32,111.36,{"name":118,"etf":119,"change":120,"price":121,"is_up":13},"Consumer Staples","XLP",-0.12,81.7,{"name":123,"etf":124,"change":125,"price":126,"is_up":13},"Energy","XLE",-0.58,63.38,{"name":128,"etf":129,"change":130,"price":131,"is_up":13},"Industrials","XLI",-2.18,167.84,{"name":133,"etf":134,"change":135,"price":136,"is_up":13},"Materials","XLB",-1.51,48.98,{"name":138,"etf":139,"change":64,"price":140,"is_up":13},"Real Estate","XLRE",40.57,{"name":142,"etf":143,"change":19,"price":144,"is_up":13},"Utilities","XLU",41.15,{"name":146,"etf":147,"change":148,"price":149,"is_up":13},"Comm Services","XLC",-0.35,111.26,[151,156,161,166],{"ticker":152,"name":153,"price":154,"change":155,"is_up":13},"SPY","SPDR S&P 500 ETF",777.22,-0.24,{"ticker":157,"name":158,"price":159,"change":160,"is_up":13},"QQQ","Invesco QQQ Trust",757.73,-0.25,{"ticker":162,"name":163,"price":164,"change":165,"is_up":13},"DIA","SPDR Dow Jones ETF",511.02,-0.69,{"ticker":167,"name":168,"price":169,"change":64,"is_up":13},"IWM","iShares Russell 2000",277.7,{"ticker":4,"count":171,"articles":172},9,[173,179,185,191,197,202,208,213,218],{"title":174,"link":175,"pubDate":176,"description":177,"source":178},"ProQR Therapeutics N.V. (PRQR) Shareholder\u002FAnalyst Call - Slideshow (NASDAQ:PRQR) 2026-09-30 - Seeking Alpha","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipgFBVV95cUxOV0R6YVRmLWw2YjQtN3pXSkdaWG5SOU54aUpWNmE0S0Q0QmN6VV9FLTNQUXg4dVdJa1dKc1VOWHpGWXFERjVreHNpRUx5SFZOeU02eHlBNC11MDRKNTVMcENJanZhU3ZqQkVKS3F4Q1BWMmRfWnJjMXl5QmtBelVybnk5MWY2U052ZGRqbUtpRS1wLTFKMkRyTzdLUGw2MmNmdWt4Wnln?oc=5","Wed, 30 Sep 2026 23:07:32 GMT","ProQR Therapeutics N.V. (PRQR) Shareholder\u002FAnalyst Call - Slideshow (NASDAQ:PRQR) 2026-09-30 Seeking Alpha","Seeking Alpha",{"title":180,"link":181,"pubDate":182,"description":183,"source":184},"HC Wainwright Cuts ProQR Therapeutics (NASDAQ:PRQR) Price Target to $8.00 - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi0gFBVV95cUxOdE1pM0tjRUhSalV4NklpajAyMWNlaE93djJhekhNYlh4MzlxMGVTMjJTOXNoejJBQWhXWmdMV3Q3Y2FLSGFPaVUtcHBIV2c1b1Njc21ZSm4wRGpFQi0wSElPVThMZUQzYkVXRFRBd1M2allWYjdnVFFJN0NBNWYtTHlNTWRjcE00QUlsNnBLSnZNelc5NXU2U0dHRWQ2RlBhLU9DZnBsSk8tMmFpOGtzVnhvNGFfRExBYVRYT01TNG1JWFhKMHBxQ2wyT2xXbU9qekE?oc=5","Thu, 01 Oct 2026 12:18:06 GMT","HC Wainwright Cuts ProQR Therapeutics (NASDAQ:PRQR) Price Target to $8.00 MarketBeat","MarketBeat",{"title":186,"link":187,"pubDate":188,"description":189,"source":190},"PRQR Oct 2026 1.000 call (PRQR261016C00001000) Stock Price, News, Quote & History - Yahoo! Finance Canada","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiZkFVX3lxTE05blVXWnBFWkFnZWhZWWVxcll3Y2toZ3VLRUlsaVA5MXh1UlBneFZWRVBkNEJpank1dlVKcGJtVVRIQXRFTlFkblpEQ0J2RU9HeGVKUFAwc3kyLUFIZjYxMEVCVE9mZw?oc=5","Tue, 06 Oct 2026 11:59:26 GMT","PRQR Oct 2026 1.000 call (PRQR261016C00001000) Stock Price, News, Quote & History Yahoo! Finance Canada","Yahoo! Finance Canada",{"title":192,"link":193,"pubDate":194,"description":195,"source":196},"PRQR Maintained by Chardan Capital -- Price Target Holds at $3.0 - GuruFocus","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMioAFBVV95cUxOUjlCOG12MnV0VEtJT0VxSnllNl9sN2pyZWJ3OEVPTjZiYlZXR0ZsUzdLVjhZUXhaNlNCa2UxRDQzak5UMXZFaDE2SzB3YXRZOG9jb09sMUlDcTRxWHB2MFJRc2FxWmdGV2pNYUFacjB3X3Ewbld6V1lIZ1hoUjlzTlZBT2FWekxETWR2UDQ2S3lJNEQ0Rk1MS29fdS1yZndB?oc=5","Thu, 01 Oct 2026 14:51:07 GMT","PRQR Maintained by Chardan Capital -- Price Target Holds at $3.0 GuruFocus","GuruFocus",{"title":198,"link":199,"pubDate":200,"description":201,"source":184},"ProQR Therapeutics' (PRQR) \"Buy\" Rating Reiterated at Chardan Capital - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixAFBVV95cUxNU3NrSEt1SDJGbHgzOElBNlRaSGh0czZIRnNESlAtM1hTNnVzWEI3Wm9ZNlJQY1VTclQyaUg2amhkZ3d5M1FkX1hyN1NUeFpwMXpFQUFoYWc2ZnZ0d1Z0aXk1cEJ6UC1xTGlDeG9LcERVMWt1cWw1VHJsZmZBbDVXX0ZYWnZaRzd3Z1l2M3VNZUhZUXl0N3FnUzZTZ1ktX0NUNm1aZWhzdFR0U3BaRGtGTUVXLUtWQlgyc0lLUW1jM3NPUEFS?oc=5","Thu, 01 Oct 2026 12:30:21 GMT","ProQR Therapeutics' (PRQR) \"Buy\" Rating Reiterated at Chardan Capital MarketBeat",{"title":203,"link":204,"pubDate":205,"description":206,"source":207},"Chardan Capital maintains Buy rating on ProQR Therapeutics, $3 price target - TradingView","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi0AFBVV95cUxNekdCZURoY2F3RUF0RkNnZktKWk14aTJWZVRDS3Z0UTRIMW81ZDg3OE0zanRyeFpsOHV3RmJnSW9rXzJlNHhSRjBGY2xoQkg4eTVSbzN1ellYQUlteWwtMWtsNnFLbm10Q1dCM3d5dFFuVFAxM2tYVmpKaVlZaG9wNF9RWWNRc1pQUGs0YkVTQVpiQlM5Y21KM0Y3V29MUjRjVTJrVUJlbV9ZLW5XblF3M3pnSWtiRjVMbmIwSDZWX05XbllLblM3QS12SFRvblJI?oc=5","Thu, 01 Oct 2026 12:10:36 GMT","Chardan Capital maintains Buy rating on ProQR Therapeutics, $3 price target TradingView","TradingView",{"title":209,"link":210,"pubDate":211,"description":212,"source":196},"PRQR Maintains Rating by HC Wainwright & Co. -- Price Target Low - GuruFocus","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMirAFBVV95cUxOVDhIWXVCQVI0UUNVVzU5ZlRXenlrUHJrZjdWcWtCS09peEVjNS1IZVRVNHVlLUtmczVaRjd1NERYb04tVWUzOC1yY2d4QUNhV0dkSUQxQzBIZks5dlprRHRWLVNRTDJrdWp5MFhqS1VWWVRqRFYxSjR6bnRERDd4ZVlRTE1CQ2Y0LXF6TkhidW1zdlFyQ2Y4N2FyMnlXc3l0OG8wMjc5ajlENmJs?oc=5","Thu, 01 Oct 2026 14:11:19 GMT","PRQR Maintains Rating by HC Wainwright & Co. -- Price Target Low GuruFocus",{"title":214,"link":215,"pubDate":216,"description":217,"source":184},"FY2028 Earnings Estimate for PRQR Issued By HC Wainwright - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivgFBVV95cUxNb0MxOW5KWkIxMjdYUmtPSXh4Y1ZJbm9IOGJrbDM4NEdiNnNvZ2VjMXJMV0FvbFk4dnI3My05MmEwRkZvY3oyTlhVV2tJY3lsUmVrNDZkbWJOcEJTNVJmQWNDQjU5VHAzMm03MWJ5U1VvblUyamZ6VVd1QzZPTjJJanQ1RWdZcmtzNW5oVVZieC1rSFZJV1cyUTJZSUhuc21HUzZBdlZVZjViZ1owQTdPZHVmZVlYckJiSHEtRUFn?oc=5","Mon, 05 Oct 2026 05:33:26 GMT","FY2028 Earnings Estimate for PRQR Issued By HC Wainwright MarketBeat",{"title":219,"link":220,"pubDate":221,"description":222,"source":223},"PRQR Q2 2026 Earnings: Narrower-Than-Expected Loss Beats Consensus Estimate - Margin Guidance - www.dars.gov.et","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiswFBVV95cUxONms2TWttTjRWZEJmT0pHNU43ZW1ueV9VXzJuTWJvTEZLT1FqX09yLWhuUnRVQnpreFQzbGFGU0VuWjlTWGU3bDJFdWRJSGhDMHVuSkhILUhpcDBnRWsxdGh6YlhtbTRHdU9raWpsYUNpQ3dKX3cwQ0ZJUUwyc01wWTVpWEZSVFJvWklpT0dRMDc4eVZYNWFaWkh5Vk9MNXR6aDRqc0s3V3VramRVZ21GTHFZYw?oc=5","Fri, 02 Oct 2026 11:31:21 GMT","PRQR Q2 2026 Earnings: Narrower-Than-Expected Loss Beats Consensus Estimate - Margin Guidance www.dars.gov.et","www.dars.gov.et"]